Figlioli G, Piovani D, Peppas S, et al. Glucagon-like peptide-1 receptor agonists and risk of gastrointestinal cancers: A systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. Published online September 7, 2024. doi:10.1016/j.phrs.2024.107401
Source link : https://www.medscape.com/s/viewarticle/glp-1-agonists-do-not-pose-gi-cancer-risk-says-meta-analysis-2024a1000gl2?src=rss
Author :
Publish date : 2024-09-16 13:00:00
Copyright for syndicated content belongs to the linked Source.